ZURA – zura bio limited - class a ordinary shares (US:NASDAQ)
Stock Stats
News
Zura Bio (ZURA) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Zura Bio (ZURA) had its price target raised by Chardan Capital from $10.00 to $11.00. They now have a "buy" rating on the stock.
Zura Bio (ZURA) had its price target lowered by Oppenheimer Holdings, Inc. from $16.00 to $15.00. They now have an "outperform" rating on the stock.
Zura Bio Reports Full Year 2025 Financial Results and Recent Corporate Updates
Zura Bio to Present Phase 2 TibuSURE Study Design Poster Evaluating Dual IL-17A and BAFF Inhibition in Systemic Sclerosis at 9th Systemic Sclerosis World Congress
Form 4 Zura Bio Ltd For: Apr 01 Filed by: Davis Kim
Form 4 Zura Bio Ltd For: Apr 01 Filed by: Hyllengren Eric J
Form 4 Zura Bio Ltd For: Apr 01 Filed by: Whale Gary
Form 4 Zura Bio Ltd For: Apr 01 Filed by: Nistala Kiran
Form 4 Zura Bio Ltd For: Apr 01 Filed by: Kulkarni Sandeep Chidambar
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.